A 
168,400
-16.01%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in KRW, from our data supplier.
Revenue
₩215.86bn
FY2016FY2025
Net income
₩141.67bn
FY2016FY2025
Free cash flow
₩90.71bn
FY2016FY2025
Shareholders' equity
₩445.19bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₩215.86bn | ₩102.85bn | ₩96.52bn | ₩28.81bn | ₩41.12bn | ₩42.43bn | ₩29.23bn | ₩13.70bn | ₩12.10bn | ₩6.84bn |
| Research and development | ₩37.05bn | ₩24.55bn | ₩25.31bn | ₩18.66bn | ₩7.44bn | ₩7.69bn | — | ₩5.96bn | ₩4.65bn | ₩3.98bn |
| Operating income | ₩106.90bn | ₩22.88bn | −₩8.35bn | −₩18.26bn | −₩1.01bn | ₩136.1m | −₩2.25bn | −₩7.65bn | −₩7.71bn | −₩5.41bn |
| Net income | ₩141.67bn | ₩62.25bn | −₩3.37bn | −₩8.15bn | ₩6.00bn | −₩969.6m | −₩704.5m | −₩6.87bn | −₩7.45bn | −₩3.59bn |
| Diluted earnings per share | 2,648.85 | 1,168.07 | -65.16 | -158.19 | 141.85 | -23.02 | -16.90 | -271.78 | -295.35 | -96.08 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | ₩698.74bn | ₩409.01bn | ₩256.10bn | ₩245.49bn | ₩260.34bn | ₩159.21bn | ₩85.98bn | ₩71.38bn | ₩43.01bn | ₩47.95bn |
| Cash and short-term investments | — | ₩184.25bn | ₩110.61bn | ₩127.54bn | ₩202.00bn | ₩133.66bn | ₩61.98bn | ₩52.52bn | ₩33.43bn | ₩37.32bn |
| Total liabilities | ₩244.30bn | ₩134.92bn | ₩108.26bn | ₩96.73bn | ₩123.61bn | ₩28.04bn | ₩16.00bn | ₩4.76bn | ₩3.17bn | ₩2.72bn |
| Debt | ₩4.03bn | ₩101.55bn | ₩83.77bn | ₩85.50bn | ₩114.61bn | ₩14.21bn | ₩5.85bn | ₩1.80bn | — | — |
| Shareholders' equity | ₩445.19bn | ₩273.59bn | ₩148.11bn | ₩148.76bn | ₩136.73bn | ₩131.16bn | ₩69.98bn | ₩66.63bn | ₩39.85bn | ₩45.23bn |
| Shares outstanding | 53m | 53m | 52m | 51m | 42m | 42m | 42m | 25m | 25m | 37m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | ₩124.13bn | ₩53.04bn | −₩7.77bn | −₩17.87bn | −₩9.46bn | ₩1.51bn | ₩9.13bn | −₩9.11bn | −₩4.35bn | −₩3.16bn |
| Capital spending | −₩33.42bn | −₩24.45bn | −₩43.44bn | −₩6.42bn | −₩13.59bn | −₩5.12bn | −₩8.16bn | −₩7.20bn | −₩706.5m | −₩2.55bn |
| Free cash flow | ₩90.71bn | ₩28.60bn | −₩51.21bn | −₩24.30bn | −₩23.05bn | −₩3.61bn | ₩969.6m | −₩16.31bn | −₩5.05bn | −₩5.71bn |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩68.89bn | ₩71.60bn | ₩64.51bn | ₩49.01bn | ₩18.64bn | ₩83.70bn | ₩50.83bn | ₩4.89bn |
| Operating income | ₩34.18bn | ₩39.30bn | ₩19.64bn | ₩30.41bn | ₩1.34bn | ₩61.02bn | ₩20.33bn | −₩8.21bn |
| Net income | ₩28.42bn | ₩71.70bn | ₩69.24bn | ₩22.34bn | −₩33.09bn | ₩83.18bn | ₩53.50bn | −₩9.30bn |
| Diluted earnings per share | 408.53 | 1,030.68 | 995.85 | 321.39 | -476.35 | 1,560.68 | 1,003.86 | -174.97 |
| Cash from operations | ₩16.56bn | ₩20.99bn | ₩65.02bn | −₩4.88bn | ₩68.80bn | −₩4.82bn | ₩53.04bn | ₩29.99bn |
| Capital spending | −₩2.58bn | −₩14.21bn | −₩15.95bn | −₩7.93bn | −₩5.48bn | −₩4.35bn | −₩24.45bn | −₩21.75bn |
| Free cash flow | ₩13.98bn | ₩6.78bn | ₩49.07bn | −₩12.81bn | ₩63.32bn | −₩9.17bn | ₩28.60bn | ₩8.23bn |
| Total assets | ₩739.91bn | ₩729.47bn | ₩698.74bn | ₩639.48bn | ₩602.89bn | ₩650.30bn | ₩409.01bn | ₩299.40bn |
| Cash and short-term investments | — | — | — | — | — | ₩329.80bn | ₩184.25bn | ₩152.72bn |
| Debt | ₩3.19bn | ₩3.61bn | ₩4.03bn | ₩4.44bn | ₩5.00bn | ₩10.14bn | ₩10.09bn | ₩11.46bn |
| Shareholders' equity | ₩536.47bn | ₩503.78bn | ₩445.19bn | ₩373.72bn | ₩343.49bn | ₩368.32bn | ₩273.59bn | ₩177.35bn |
Financial ratios
Data as of 26 Aug 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating margin | 49.5% | 22.2% | -8.6% | -63.4% | -2.5% | 0.3% | — | — |
| Net margin | 65.6% | 60.5% | -3.5% | -28.3% | 14.6% | -2.3% | — | — |
| Return on equity | 31.8% | 22.8% | -2.3% | -5.5% | 4.4% | -0.7% | — | — |
| Return on assets | 20.3% | 15.2% | -1.3% | -3.3% | 2.3% | -0.6% | — | — |
| Free cash flow yield | — | — | — | — | — | — | -0.0% | -0.0% |
| Revenue growth | 109.9% | 6.6% | 235.1% | -30.0% | -3.1% | 45.1% | — | — |
| Earnings growth | 127.6% | -1946.3% | -58.6% | -235.7% | -718.9% | 37.6% | — | — |
| Current ratio | 2.01x | 1.64x | 1.43x | 10.61x | 17.67x | 12.46x | — | — |
| Debt to equity | 0.01x | 0.04x | 0.01x | 0.03x | 0.02x | 0.03x | — | — |
| Equity ratio | 63.7% | 66.9% | 57.8% | 60.6% | 52.5% | 82.4% | — | — |
| Interest coverage | 9.75x | 33.90x | -12.44x | -42.91x | -1.67x | 0.17x | — | — |
| R&D as a share of sales | 17.2% | 23.9% | 26.2% | 64.8% | 18.1% | 18.1% | — | — |
| Buybacks as a share of market value | — | — | — | — | — | — | -0.3% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 95.7% | 38.5% | 46.5% |
| Operating income | — | 279.3% | 96.6% |
| Net income | — | — | 61.0% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 40.7% | 23.2% | 19.4% | 13.4% |
| Net margin | 64.0% | 43.3% | 37.4% | 30.3% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 130.5 | 203.8 | -1162.8 | -186.0 | 342.1 | -3336.3 | -845.9 | -22.5 | -16.1 | -36.4 |
| Price to sales | 85.7 | 123.4 | 40.6 | 52.6 | 49.9 | 76.3 | 20.4 | 11.3 | 9.9 | 19.1 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 6-for-5 split · 25 Oct 2022
- 3-for-2 split · 24 Mar 2021
- 2-for-1 split · 23 Jul 2020
- 2-for-1 split · 7 Dec 2017
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.